DK0927165T3 - Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer - Google Patents

Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer

Info

Publication number
DK0927165T3
DK0927165T3 DK97941402T DK97941402T DK0927165T3 DK 0927165 T3 DK0927165 T3 DK 0927165T3 DK 97941402 T DK97941402 T DK 97941402T DK 97941402 T DK97941402 T DK 97941402T DK 0927165 T3 DK0927165 T3 DK 0927165T3
Authority
DK
Denmark
Prior art keywords
protease inhibitors
hiv protease
intermediates
preparation
producing
Prior art date
Application number
DK97941402T
Other languages
English (en)
Inventor
Kathleen R Whitten
Michael E Deason
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Application granted granted Critical
Publication of DK0927165T3 publication Critical patent/DK0927165T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97941402T 1996-09-05 1997-09-04 Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer DK0927165T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05
PCT/US1997/015468 WO1998009951A2 (en) 1996-09-05 1997-09-04 Intermediates for making hiv-protease inhibitors and methods of making hiv-protease inhibitors

Publications (1)

Publication Number Publication Date
DK0927165T3 true DK0927165T3 (da) 2004-03-15

Family

ID=24845703

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03013275T DK1361216T3 (da) 1996-09-05 1997-09-04 Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor
DK97941402T DK0927165T3 (da) 1996-09-05 1997-09-04 Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK03013275T DK1361216T3 (da) 1996-09-05 1997-09-04 Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor

Country Status (33)

Country Link
EP (2) EP0927165B1 (da)
JP (3) JP4149000B2 (da)
KR (1) KR100563289B1 (da)
CN (2) CN1305854C (da)
AP (2) AP1322A (da)
AT (2) ATE309990T1 (da)
AU (2) AU740369B2 (da)
BG (2) BG64793B1 (da)
BR (1) BR9713192A (da)
CA (1) CA2264756A1 (da)
CZ (2) CZ298174B6 (da)
DE (2) DE69734689T2 (da)
DK (2) DK1361216T3 (da)
EA (1) EA002051B1 (da)
EE (1) EE04465B1 (da)
ES (2) ES2210573T3 (da)
GE (1) GEP20022799B (da)
HK (1) HK1062171A1 (da)
HU (1) HUP0000028A3 (da)
IL (1) IL128567A (da)
IS (1) IS2030B (da)
NO (1) NO313287B1 (da)
NZ (1) NZ334909A (da)
OA (1) OA10988A (da)
PL (2) PL198408B1 (da)
PT (1) PT927165E (da)
SG (1) SG94780A1 (da)
SI (2) SI1361216T1 (da)
SK (2) SK284899B6 (da)
TR (1) TR199900473T2 (da)
UA (1) UA67727C2 (da)
WO (1) WO1998009951A2 (da)
YU (1) YU11599A (da)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
AU4953796A (en) * 1995-03-15 1996-10-02 Sanyko Company, Limited Dipeptide compounds having ahpba structure
DE69634345T2 (de) * 1995-09-26 2006-03-02 Japan Tobacco Inc. Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen
EP0984000B1 (en) * 1995-09-26 2008-12-03 Japan Tabacco Inc. Process for producing amide derivatives and intermediate compounds
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
WO1997030993A1 (de) * 1996-02-24 1997-08-28 Basf Aktiengesellschaft Pyrazol-4-yl-hetaroylderivate als herbizide

Also Published As

Publication number Publication date
HUP0000028A3 (en) 2003-05-28
PL201758B1 (pl) 2009-05-29
DE69734689T2 (de) 2006-06-08
CZ298174B6 (cs) 2007-07-11
CA2264756A1 (en) 1998-03-12
IL128567A0 (en) 2000-01-31
AP9901497A0 (en) 1999-06-30
CN1537846A (zh) 2004-10-20
PT927165E (pt) 2004-04-30
AU1473602A (en) 2002-03-14
EP1361216A1 (en) 2003-11-12
ES2210573T3 (es) 2004-07-01
NO991072L (no) 1999-03-04
TR199900473T2 (xx) 1999-06-21
DE69726298T2 (de) 2004-05-27
CZ298175B6 (cs) 2007-07-11
JP4149000B2 (ja) 2008-09-10
ATE254603T1 (de) 2003-12-15
ES2252586T3 (es) 2006-05-16
IS4982A (is) 1999-02-19
EP0927165B1 (en) 2003-11-19
EA002051B1 (ru) 2001-12-24
JP2001500495A (ja) 2001-01-16
HK1062171A1 (en) 2004-10-21
WO1998009951A3 (en) 1998-07-09
JP2008056693A (ja) 2008-03-13
UA67727C2 (uk) 2004-07-15
SI1361216T1 (sl) 2006-02-28
IL128567A (en) 2004-03-28
SG94780A1 (en) 2003-03-18
AP1322A (en) 2004-11-04
PL331801A1 (en) 1999-08-02
SI0927165T1 (en) 2004-04-30
EP1361216B1 (en) 2005-11-16
KR20010029489A (ko) 2001-04-06
CN1183117C (zh) 2005-01-05
OA10988A (en) 2001-11-01
WO1998009951A2 (en) 1998-03-12
NZ334909A (en) 2000-06-23
BG65237B1 (bg) 2007-09-28
EE04465B1 (et) 2005-04-15
BG64793B1 (bg) 2006-04-28
AU4331797A (en) 1998-03-26
AP2003002938A0 (en) 2003-12-31
EA199900257A1 (ru) 1999-08-26
NO991072D0 (no) 1999-03-04
DE69726298D1 (de) 2003-12-24
DE69734689D1 (de) 2005-12-22
CN1232455A (zh) 1999-10-20
AU740369B2 (en) 2001-11-01
CZ71699A3 (cs) 1999-06-16
NO313287B1 (no) 2002-09-09
GEP20022799B (en) 2002-09-25
DK1361216T3 (da) 2006-01-23
BR9713192A (pt) 1999-12-21
ATE309990T1 (de) 2005-12-15
JP2008088178A (ja) 2008-04-17
SK28299A3 (en) 1999-11-08
CN1305854C (zh) 2007-03-21
EP0927165A2 (en) 1999-07-07
YU11599A (sh) 2000-03-21
PL198408B1 (pl) 2008-06-30
AU766155B2 (en) 2003-10-09
IS2030B (is) 2005-08-15
BG103305A (en) 2000-01-31
HUP0000028A2 (hu) 2000-05-28
SK285278B6 (sk) 2006-10-05
KR100563289B1 (ko) 2006-03-22
EE9900109A (et) 1999-12-15
SK284899B6 (sk) 2006-02-02

Similar Documents

Publication Publication Date Title
IS4928A (is) Fosfín tengdir tálmar af grindar málmpróteösum
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
IS5943A (is) Aðferð og samsetningar til að endurheimta samræmdan stöðugleika próteina af p53 ættinni
DK0922040T3 (da) Fremgangsmåde til fremstilling af mellemprodukter til florfenicol
DK21995A (da) Forbinding og fremgangsmade til fremstilling af forbinding
DK1726658T3 (da) Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
NO983957L (no) FremgangsmÕte ved sammenf°yning av tofase rustfritt stÕl
DK0876573T3 (da) Keramisk tænder og fremgangsmåde til anvendelse af samme
DK0970077T3 (da) Forbedret fremgangsmåde til fremstilling af thiazolidindioner og nye thiazolidindioner
DK1003528T3 (da) Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater
DK0803576T3 (da) Fremgangsmåde til fremstilling af lipstatin og tetrahydrolipstatin
NO990913L (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
DK0987356T3 (da) Fremgangsmåde til trækning
DK0874822T3 (da) Ny fremgangsmåde til fremstilling
DK1066276T3 (da) Fremgangsmåde til syntese af HIV protease inhibitor
DK0983249T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1039888T3 (da) Fremgangsmåde til forøgelse af produktionen og forbedring af kvaliteten af sæd
DK0905128T3 (da) Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater
DK0927165T3 (da) Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer
DK0930297T3 (da) Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter
DK0694617T3 (da) Fremgangsmåde til amplifikation ved anvendelse af intermediære renatureringstrin
DK0707078T3 (da) Ny fremgangsmåde til fortrængning af sukkerrörssaft